Oncotelic Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Oncotelic's estimated annual revenue is currently $4.2M per year.(i)
  • Oncotelic's estimated revenue per employee is $155,000

Employee Data

  • Oncotelic has 27 Employees.(i)
  • Oncotelic grew their employee count by 13% last year.

Oncotelic's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
CMOReveal Email/Phone
3
Chief Clinical Officer-Translational MedicineReveal Email/Phone
4
Product ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Oncotelic?

Oncotelic /Mateon is a convergent of PointR AI clustercomputing, Oncotelic antisense platform, and Mateon vascular disrupting agent. Lead asset OT-101 is an antisense against TGF-beta for cancer, covid-19, and other viruses

keywords:N/A

N/A

Total Funding

27

Number of Employees

$4.2M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.6M2912%N/A
#2
$2.9M29-9%N/A
#3
$4.9M3011%N/A
#4
$2.4M3025%N/A
#5
$5.4M3343%N/A